Syndax Pharmaceuticals Inc
NASDAQ:SNDX
Income Statement
Earnings Waterfall
Syndax Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-230m
USD
|
Operating Income
|
-230m
USD
|
Other Expenses
|
20.6m
USD
|
Net Income
|
-209.4m
USD
|
Income Statement
Syndax Pharmaceuticals Inc
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+100%
|
1
+50%
|
1
+33%
|
1
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
1
N/A
|
2
+75%
|
2
+5%
|
2
+5%
|
2
+4%
|
2
-38%
|
2
+7%
|
2
N/A
|
2
N/A
|
2
-6%
|
2
+7%
|
2
N/A
|
2
N/A
|
2
-6%
|
2
+7%
|
2
N/A
|
14
+750%
|
140
+927%
|
139
0%
|
139
0%
|
127
-9%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(7)
|
(9)
|
(11)
|
(16)
|
(21)
|
(18)
|
(18)
|
(16)
|
(21)
|
(26)
|
(29)
|
(39)
|
(45)
|
(49)
|
(55)
|
(55)
|
(64)
|
(71)
|
(76)
|
(78)
|
(77)
|
(72)
|
(69)
|
(64)
|
(59)
|
(59)
|
(61)
|
(67)
|
(73)
|
(85)
|
(91)
|
(103)
|
(114)
|
(123)
|
(138)
|
(141)
|
(152)
|
(161)
|
(173)
|
(194)
|
(230)
|
|
Selling, General & Administrative |
(4)
|
(5)
|
(6)
|
(7)
|
(11)
|
(10)
|
(12)
|
(9)
|
(12)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(15)
|
(15)
|
(16)
|
(17)
|
(17)
|
(18)
|
(17)
|
(16)
|
(15)
|
(15)
|
(16)
|
(18)
|
(21)
|
(23)
|
(23)
|
(22)
|
(22)
|
(23)
|
(25)
|
(26)
|
(29)
|
(30)
|
(33)
|
(38)
|
(45)
|
(54)
|
(67)
|
|
Research & Development |
(3)
|
(3)
|
(5)
|
(9)
|
(9)
|
(8)
|
(6)
|
(7)
|
(10)
|
(13)
|
(17)
|
(26)
|
(32)
|
(37)
|
(40)
|
(40)
|
(48)
|
(54)
|
(59)
|
(61)
|
(60)
|
(56)
|
(54)
|
(49)
|
(43)
|
(41)
|
(40)
|
(44)
|
(50)
|
(63)
|
(69)
|
(80)
|
(88)
|
(96)
|
(109)
|
(111)
|
(119)
|
(123)
|
(128)
|
(140)
|
(163)
|
|
Operating Income |
(7)
N/A
|
(9)
-19%
|
(11)
-31%
|
(16)
-37%
|
(21)
-32%
|
(18)
+10%
|
(18)
+4%
|
(16)
+10%
|
(21)
-30%
|
(25)
-21%
|
(28)
-12%
|
(37)
-33%
|
(44)
-17%
|
(48)
-10%
|
(53)
-11%
|
(54)
0%
|
(62)
-16%
|
(69)
-10%
|
(74)
-8%
|
(76)
-3%
|
(76)
+0%
|
(71)
+7%
|
(67)
+5%
|
(63)
+7%
|
(58)
+8%
|
(58)
-1%
|
(59)
-2%
|
(66)
-12%
|
(71)
-9%
|
(84)
-17%
|
(89)
-7%
|
(89)
0%
|
26
N/A
|
17
-37%
|
1
-93%
|
(14)
N/A
|
(152)
-984%
|
(161)
-6%
|
(173)
-7%
|
(194)
-12%
|
(230)
-18%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
0
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
3
|
8
|
13
|
18
|
21
|
|
Total Other Income |
(2)
|
(5)
|
(6)
|
(2)
|
(1)
|
2
|
(1)
|
(2)
|
(2)
|
(4)
|
(3)
|
(2)
|
(2)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
1
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(12)
N/A
|
(14)
-23%
|
(17)
-21%
|
(18)
-4%
|
(22)
-22%
|
(17)
+20%
|
(19)
-10%
|
(19)
+1%
|
(24)
-28%
|
(30)
-22%
|
(32)
-7%
|
(39)
-23%
|
(45)
-14%
|
(47)
-6%
|
(52)
-11%
|
(53)
0%
|
(61)
-16%
|
(67)
-11%
|
(72)
-7%
|
(74)
-3%
|
(74)
+0%
|
(69)
+7%
|
(65)
+5%
|
(61)
+7%
|
(56)
+8%
|
(57)
-2%
|
(59)
-4%
|
(67)
-13%
|
(73)
-10%
|
(86)
-17%
|
(91)
-7%
|
(92)
0%
|
25
N/A
|
16
-38%
|
1
-95%
|
(14)
N/A
|
(149)
-966%
|
(153)
-3%
|
(160)
-5%
|
(176)
-10%
|
(209)
-19%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(12)
|
(14)
|
(17)
|
(18)
|
(22)
|
(17)
|
(19)
|
(19)
|
(24)
|
(30)
|
(32)
|
(39)
|
(45)
|
(47)
|
(52)
|
(53)
|
(61)
|
(67)
|
(72)
|
(74)
|
(74)
|
(69)
|
(65)
|
(61)
|
(56)
|
(57)
|
(59)
|
(67)
|
(73)
|
(86)
|
(91)
|
(92)
|
25
|
16
|
1
|
(14)
|
(149)
|
(153)
|
(160)
|
(176)
|
(209)
|
|
Net Income (Common) |
(51)
N/A
|
(60)
-19%
|
(65)
-7%
|
(67)
-4%
|
(33)
+50%
|
(28)
+17%
|
(48)
-73%
|
(95)
-99%
|
(104)
-9%
|
(105)
-1%
|
(87)
+17%
|
(45)
+48%
|
(47)
-4%
|
(47)
0%
|
(52)
-11%
|
(53)
0%
|
(61)
-16%
|
(67)
-11%
|
(72)
-7%
|
(74)
-3%
|
(74)
+0%
|
(69)
+7%
|
(65)
+5%
|
(61)
+7%
|
(56)
+8%
|
(61)
-9%
|
(63)
-4%
|
(71)
-12%
|
(77)
-9%
|
(86)
-11%
|
(91)
-7%
|
(92)
0%
|
25
N/A
|
16
-38%
|
1
-95%
|
(14)
N/A
|
(149)
-966%
|
(153)
-3%
|
(160)
-5%
|
(176)
-10%
|
(209)
-19%
|
|
EPS (Diluted) |
-2.93
N/A
|
-3.49
-19%
|
-3.74
-7%
|
-3.81
-2%
|
-1.92
+50%
|
-1.58
+18%
|
-2.75
-74%
|
-5.47
-99%
|
-5.98
-9%
|
-5.88
+2%
|
-4.87
+17%
|
-2.51
+48%
|
-3.22
-28%
|
-2.59
+20%
|
-2.68
-3%
|
-2.36
+12%
|
-2.9
-23%
|
-2.74
+6%
|
-2.91
-6%
|
-2.9
+0%
|
-2.92
-1%
|
-2.54
+13%
|
-2.06
+19%
|
-1.92
+7%
|
-1.84
+4%
|
-1.77
+4%
|
-1.55
+12%
|
-1.59
-3%
|
-1.87
-18%
|
-1.66
+11%
|
-1.77
-7%
|
-1.76
+1%
|
0.46
N/A
|
0.26
-43%
|
0.01
-96%
|
-0.23
N/A
|
-2.46
-970%
|
-2.2
+11%
|
-2.3
-5%
|
-2.51
-9%
|
-2.98
-19%
|